GENEVA, Aug. 14 -- LEIBNIZ-INSTITUT FÜR IMMUNTHERAPIE (LIT) filed a patent application (EP2026/053295) for “AN ANTI-HER2 SCFV-SECRETING ARMOURED CAR T CELL”. With publication no. WO/2026/167227, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61P 35/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....